Travere Therapeutics, Inc.
USD57.84
-0.46 (-0.78%)
CEO
Eric Dube
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.61
Prev. Close
$58.30
Day Low
$57.77
Day High
$58.69
52W Low
$14.36
52W High
$60.10
Market Cap
$5.38B
Volume
0.62M
| 10,000 |
| $26.52 |
| 16 Jun 2026 | Coughlin Timothy | director | S-Sale | Disposed | 10,000 | $50.07 |
| 16 Jun 2026 | Coughlin Timothy | director | M-Exempt | Disposed | 10,000 | $26.52 |
| 16 Jun 2026 | Baynes Roy D. | director | M-Exempt | Acquired | 4,500 | $21.38 |
| 16 Jun 2026 | Baynes Roy D. | director | S-Sale | Disposed | 4,500 | $50.00 |
| 16 Jun 2026 | Baynes Roy D. | director | M-Exempt | Disposed | 4,500 | $21.38 |
| 21 May 2026 | Williams Brinkley Ruth | director | A-Award | Acquired | 4,000 | $0.00 |
| 21 May 2026 | Williams Brinkley Ruth | director | A-Award | Acquired | 12,000 | $42.26 |
| 21 May 2026 | Squarer Ron | director | A-Award | Acquired | 4,000 | $0.00 |